Registration Status of Benlysta® (belimumab) in Australia - GlaxoSmithKline Australia:
'via Blog this'
According to GlaxoSmithKline Australia (see link above), their application for Benlysta to be approved for treatment of lupus patients in Australia has been rejected by the Therapeutic Goods Administration. GSK is currently appealing the decision.
You might recall that there were petitions in Britain to try to have the British decision to not allow the use of Benlysta there overturned. I understand there may be a petition being circulated here in Australia soon, I will let you know as soon as I know about it.